Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Adler

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
Inflammatory Bowel Diseases|October 16, 2024
Durable Immune Response and Long-term Efficacy of COVID-19 Vaccination in Children With Inflammatory Bowel DiseaseArthur J Kastl, Erica J Brenner, Kimberly N Weaver, et al.
Inflammatory Bowel Diseases|January 24, 2025
Circulating and Magnetic Resonance Imaging Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's DiseaseJonathan R Dillman, Jean A Tkach, Joel G Fletcher, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 18, 2024
Long-Term Effectiveness and Durability of COVID-19 Vaccination Among Patients With Inflammatory Bowel DiseaseErica J Brenner, Kimberly N Weaver, Xian Zhang, et al.
The American Journal of Gastroenterology|September 17, 2022
Humoral Immune Response and Safety of SARS-CoV-2 Vaccination in Pediatric Inflammatory Bowel DiseaseArthur J Kastl, Kimberly N Weaver, Xian Zhang, et al.
The American Journal of Gastroenterology|March 6, 2024
High Body Mass Index and Response to Anti-Tumor Necrosis Factor Therapy in Pediatric Crohn's DiseaseDawn R Ebach, Traci W Jester, Joseph A Galanko, et al.
The American Journal of Gastroenterology|June 30, 2026
The Safety and Effectiveness of Early Anti-Tumor-Necrosis-Factor Therapy for Penetrating Crohn's Disease Complications in ChildrenBrad D Constant, Yixuan Feng, Jing Huang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 24, 2024
Travel Time to Treating Center Is Associated With Diagnostic Delay in Pediatric Inflammatory Bowel DiseaseJoi F McLaughlin, Tiffany Linville, Traci W Jester, et al.
The American Journal of Gastroenterology|May 2, 2025
HLA DQA1*05 and Risk of Antitumor Necrosis Factor Treatment Failure and Anti-Drug Antibody Development in Children With Crohn's DiseaseJeremy Adler, Joseph A Galanko, Rana Ammoury, et al.
The American Journal of Gastroenterology|October 18, 2024
HLA DQA1*05 and risk of anti-TNF treatment failure and anti-drug antibody development in children with Crohn's Disease: HLA DQA1*05 and Pediatric Crohn's DiseaseJeremy Adler, Joseph A Galanko, Rana Ammoury, et al.
Inflammatory Bowel Diseases|October 17, 2024
Low Anti-Tumor Necrosis Factor Levels During Maintenance Phase Are Associated With Treatment Failure in Children With Crohn's DiseaseJonathan Moses, Jeremy Adler, Shehzad A Saeed, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Inflammatory Bowel Diseases|October 16, 2024
Durable Immune Response and Long-term Efficacy of COVID-19 Vaccination in Children With Inflammatory Bowel DiseaseArthur J Kastl, Erica J Brenner, Kimberly N Weaver, et al.
Inflammatory Bowel Diseases|January 24, 2025
Circulating and Magnetic Resonance Imaging Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's DiseaseJonathan R Dillman, Jean A Tkach, Joel G Fletcher, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 18, 2024
Long-Term Effectiveness and Durability of COVID-19 Vaccination Among Patients With Inflammatory Bowel DiseaseErica J Brenner, Kimberly N Weaver, Xian Zhang, et al.
The American Journal of Gastroenterology|September 17, 2022
Humoral Immune Response and Safety of SARS-CoV-2 Vaccination in Pediatric Inflammatory Bowel DiseaseArthur J Kastl, Kimberly N Weaver, Xian Zhang, et al.
The American Journal of Gastroenterology|March 6, 2024
High Body Mass Index and Response to Anti-Tumor Necrosis Factor Therapy in Pediatric Crohn's DiseaseDawn R Ebach, Traci W Jester, Joseph A Galanko, et al.
The American Journal of Gastroenterology|June 30, 2026
The Safety and Effectiveness of Early Anti-Tumor-Necrosis-Factor Therapy for Penetrating Crohn's Disease Complications in ChildrenBrad D Constant, Yixuan Feng, Jing Huang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 24, 2024
Travel Time to Treating Center Is Associated With Diagnostic Delay in Pediatric Inflammatory Bowel DiseaseJoi F McLaughlin, Tiffany Linville, Traci W Jester, et al.
The American Journal of Gastroenterology|May 2, 2025
HLA DQA1*05 and Risk of Antitumor Necrosis Factor Treatment Failure and Anti-Drug Antibody Development in Children With Crohn's DiseaseJeremy Adler, Joseph A Galanko, Rana Ammoury, et al.
The American Journal of Gastroenterology|October 18, 2024
HLA DQA1*05 and risk of anti-TNF treatment failure and anti-drug antibody development in children with Crohn's Disease: HLA DQA1*05 and Pediatric Crohn's DiseaseJeremy Adler, Joseph A Galanko, Rana Ammoury, et al.
Inflammatory Bowel Diseases|October 17, 2024
Low Anti-Tumor Necrosis Factor Levels During Maintenance Phase Are Associated With Treatment Failure in Children With Crohn's DiseaseJonathan Moses, Jeremy Adler, Shehzad A Saeed, et al.
Pageof 14